Mianyang People's Hospital Has Become the National Clinical Cooperation Base for Gene Detection Technology
2018-05-25

(Mianyang News) (Li Linman, Sun Zhongxian, Peng Xue/reporter) Recently, the clinical cooperation base of national demonstration center of gene detection technology application and the pilot unit of the individual medical testing landed in Mianyang People's Hospital, marking that Mianyang People's Hospital has the ability to carry out a number of genetic testing projects.

Gene detection can realize the prediction, prevention, prognosis and individualized diagnosis and treatment of major diseases, which occupies an important position in clinical medical applications. At present, more than 1500 kinds of diseases can be detected by using gene detection technology. It will be applied to prenatal detection, diagnosis and oncogene detection in Mianyang. It is understood in the middle of pregnancy all pregnant women need to be undergone the Down's screening; the current screening means includes the traditional serology Down's screening and non-invasive DNA detection. The non-invasive DNA prenatal detection technology is to sequence the fetal free DNA fragments in maternal peripheral blood by using a new generation of high-throughput sequencing technology; it can obtain the risk rate of 21-triad, 18-trisomy and 13-trisomy syndrome by bioinformatics analysis. The accuracy of this method is much higher than that of general Down's screening, and there is no risk of invasion and abortion. The landing of national clinical cooperation base of gene detection technology in Mianyang will provide important data and clinical support for the development of gene detection technology, and better serve the major disease detection and prevention of Mianyang citizens.